Accumulated allelic losses in the development of invasive urothelial cancer

International Journal of Cancer - Tập 53 Số 4 - Trang 579-584 - 1993
Tomonori Habuchi1, Osamu Ogawa2, Yoshiyuki Kakehi2, Keiji Ogura2, M. Koshiba3, Shuji Hamazaki4, Rei Takahashi4, Taketoshi Sugiyama4, Osamu Yoshida2
1Department of Urology, Faculty of medicine, Kyoto University, Japan.
2Departments of Urology, Faculty of Medicine, Kyoto University, 54 Kawahara‐cho, Shogoin, Sakyo‐ku, Kyoto 606, Japan
3Departments of Geriatric Medicine Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606, Japan
4Departments of Pathology Faculty of Medicine, Kyoto University, 54 Kawahara‐cho, Shogoin, Sakyo‐ku, Kyoto 606, Japan

Tóm tắt

AbstractTo investigate the roles of allelic loss in the development of urothelial cancer, loss of heterozygosity was examined on 7 chromosomal arms in 49 cases of urothelial cancer of various grades and stages. Loss of heterozygosity was found on alleles in order of frequency as follows: 9q (21/38, 55%), 11p (20/44, 45%), 17p (18/42,43%), 13q (10/39,26%), 3p (8/41, 20%), 10q 2/29, 7%) and 1p (1/36, 3%). lnvasive (high‐grade or ≥pT2) tumors showed the loss of 17p (13/16,81%) and the loss of 13q (7/16, 44%) with significantly higher frequencies than non‐invasive (grade 1‐2 ≤pTI ) tumors. Although the loss of 3p and the loss of 11p were also more frequently associated with the invasive phenotypes, the loss of 11p was detected in a considerable number (9 of 26,35%) of non‐invasive tumors. Our results indicate that the loss of 11p might generally occur at an earlier stage before the loss of 3p, 13q or 17p in tumor progression. Since no correlation was found between the loss of 9q and the tumor grade or stage, this genetic alteration appears to be unrelated to invasiveness, and could be one of the initial events in tumorigenesis. Although accumulated allelic losses of 3p, 11p, 13q and 17p are considered to be involved in the development of the invasive type of urothelial cancers, these multiple genetic alterations may have already occurred in some pathologically non‐invasive urothelial cancers. Furthermore, there appears to be some variation in the pattern of cumulative allelic loss.

Từ khóa


Tài liệu tham khảo

10.1093/jnci/84.7.506

10.1038/318377a0

10.1016/S0022-5347(17)36977-X

10.1016/S0022-5347(17)51695-X

Hopman A. H. N., 1991, Numeral chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization, Cancer Res., 51, 644

10.1073/pnas.87.7.2775

10.1002/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G

Ishikawa J., 1991, Inactivation of the retinoblastoma gene in human bladder and renal‐cell carcinomas, Cancer Res., 51, 5736

Kakizoe T., 1988, Relationship between papillary and nodular transitionai‐ cell carcinoma in the human urinary bladder, Cancer Res., 48, 2293

Mostofi F. K., 1988, Diagnosis and management of genitourinary cancer, 83

Mostofi F. K., 1973, Histological typing of urinay bladder tumors

10.1038/342705a0

Ogawa O., 1991, Allelic loss at chromosome 3p characterizes clear‐cell phenotype of renal‐cell carcinoma, Cancer Res, 51, 949

Olumi A. F., 1990, Allelic loss of chromosome 17p distinguishes high‐grade from low‐grade transitional‐cell carcinomas of the bladder, Cancer Res., 50, 7081

Presti J. C., 1991, Molecular genetic alterations in superficial and locally advanced human bladder cancer, Cancer Res., 51, 5405

10.1128/MCB.9.4.1799

10.1016/S0022-5347(17)59439-2

Sato T., 1991, Accumulation of genetic alterations and progression of primary breast cancer, Cancer Res., 51, 5794

10.1126/science.2024123

10.1038/355846a0

10.1016/0165-4608(87)90028-8

Tsai T. C., 1990, Allelic losses of chromosome 9, 11, and 17 in human bladder cancer, Cancer Res., 50, 44

UICC (International Union Against Cancer), 1987, TNM classification of malignant tumours

10.1056/NEJM198809013190901

10.1126/science.1659741

10.1073/pnas.86.13.5099

10.1159/000133727

Wu S.‐Q., 1991, Non‐random chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells., Cancer Res., 51, 3323